Aspergillumarin A

Details

Top
Internal ID 8c6f38e2-2f00-4fb1-8de9-2a6396aa7f04
Taxonomy Organoheterocyclic compounds > Benzopyrans > 2-benzopyrans
IUPAC Name (3R)-8-hydroxy-3-(4-oxopentyl)-3,4-dihydroisochromen-1-one
SMILES (Canonical) CC(=O)CCCC1CC2=C(C(=CC=C2)O)C(=O)O1
SMILES (Isomeric) CC(=O)CCC[C@@H]1CC2=C(C(=CC=C2)O)C(=O)O1
InChI InChI=1S/C14H16O4/c1-9(15)4-2-6-11-8-10-5-3-7-12(16)13(10)14(17)18-11/h3,5,7,11,16H,2,4,6,8H2,1H3/t11-/m1/s1
InChI Key KEYNBOUNPFJEST-LLVKDONJSA-N
Popularity 2 references in papers

Physical and Chemical Properties

Top
Molecular Formula C14H16O4
Molecular Weight 248.27 g/mol
Exact Mass 248.10485899 g/mol
Topological Polar Surface Area (TPSA) 63.60 Ų
XlogP 2.40
Atomic LogP (AlogP) 2.23
H-Bond Acceptor 4
H-Bond Donor 1
Rotatable Bonds 4

Synonyms

Top
CHEMBL2332662

2D Structure

Top
2D Structure of Aspergillumarin A

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9589 95.89%
Caco-2 + 0.6067 60.67%
Blood Brain Barrier - 0.5250 52.50%
Human oral bioavailability - 0.5000 50.00%
Subcellular localzation Mitochondria 0.6161 61.61%
OATP2B1 inhibitior - 0.8583 85.83%
OATP1B1 inhibitior + 0.9045 90.45%
OATP1B3 inhibitior + 0.9515 95.15%
MATE1 inhibitior - 0.8400 84.00%
OCT2 inhibitior - 0.8750 87.50%
BSEP inhibitior - 0.9526 95.26%
P-glycoprotein inhibitior - 0.9389 93.89%
P-glycoprotein substrate - 0.7603 76.03%
CYP3A4 substrate + 0.5078 50.78%
CYP2C9 substrate + 0.8221 82.21%
CYP2D6 substrate - 0.8597 85.97%
CYP3A4 inhibition - 0.6996 69.96%
CYP2C9 inhibition - 0.7733 77.33%
CYP2C19 inhibition - 0.7118 71.18%
CYP2D6 inhibition - 0.9153 91.53%
CYP1A2 inhibition + 0.6310 63.10%
CYP2C8 inhibition - 0.8964 89.64%
CYP inhibitory promiscuity - 0.9135 91.35%
UGT catelyzed + 0.7000 70.00%
Carcinogenicity (binary) - 0.9500 95.00%
Carcinogenicity (trinary) Non-required 0.7137 71.37%
Eye corrosion - 0.9830 98.30%
Eye irritation + 0.6793 67.93%
Skin irritation - 0.6307 63.07%
Skin corrosion - 0.8909 89.09%
Ames mutagenesis + 0.5100 51.00%
Human Ether-a-go-go-Related Gene inhibition - 0.5617 56.17%
Micronuclear - 0.8400 84.00%
Hepatotoxicity + 0.6875 68.75%
skin sensitisation - 0.9015 90.15%
Respiratory toxicity + 0.6778 67.78%
Reproductive toxicity + 0.8556 85.56%
Mitochondrial toxicity + 0.7875 78.75%
Nephrotoxicity + 0.5428 54.28%
Acute Oral Toxicity (c) III 0.5525 55.25%
Estrogen receptor binding + 0.6408 64.08%
Androgen receptor binding - 0.5753 57.53%
Thyroid receptor binding - 0.7004 70.04%
Glucocorticoid receptor binding - 0.6261 62.61%
Aromatase binding - 0.8887 88.87%
PPAR gamma + 0.7081 70.81%
Honey bee toxicity - 0.9657 96.57%
Biodegradation - 0.6500 65.00%
Crustacea aquatic toxicity - 0.6200 62.00%
Fish aquatic toxicity + 0.9845 98.45%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL2581 P07339 Cathepsin D 98.19% 98.95%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 97.22% 91.11%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 93.17% 96.09%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 92.30% 95.56%
CHEMBL3038477 P67870 Casein kinase II alpha/beta 91.85% 99.23%
CHEMBL217 P14416 Dopamine D2 receptor 90.36% 95.62%
CHEMBL1951 P21397 Monoamine oxidase A 89.81% 91.49%
CHEMBL3401 O75469 Pregnane X receptor 89.30% 94.73%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 88.55% 94.45%
CHEMBL3060 Q9Y345 Glycine transporter 2 85.93% 99.17%
CHEMBL1806 P11388 DNA topoisomerase II alpha 85.31% 89.00%
CHEMBL1293249 Q13887 Kruppel-like factor 5 85.01% 86.33%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 82.68% 85.14%
CHEMBL3137262 O60341 LSD1/CoREST complex 80.05% 97.09%

Cross-Links

Top
PubChem 38346998
NPASS NPC27407